Vivance
Singapore, SG · 4 known investors
Find your way into Vivance
243 people in our graph share verified history with the Vivance team — schools, employers, funds. One of them is your warm intro.
Angela Toyunlockedknows Suresha Venkataraya · together at Nanyang Technological University Singapore (overlapped)
×5knows the team · via Nanyang Technological University Singapore
×2knows the team · via A*STAR - Agency for Science, Technology and Research
knows the team · via Visvesvaraya Technological University
knows the team · via CareFusion
×2knows the team · via University of Alabama at Birmingham
AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.
Founders & leadership
SV
Suresha VenkatarayainChief Executive OfficerCEO of Vivance, Suresha previously held leadership roles at Hill-Rom, a major medical devices manufacturer, where he oversaw product development and commercialization across dialysis, respiratory care, and monitoring technologies, and before that worked as a technical leader at Robert Bosch on automotive systems. He holds a Master of Science in Computer Control Systems from Nanyang Technological University and a Bachelor of Engineering in Electronics and Communication Engineering from Visvesvaraya Technological University.
MG
Mandar GoriinChief Business OfficerMandar Gori is Chief Business Officer of Vivance Inc., a wearable dialysis device company, where he oversees commercial, clinical, and business development functions. He brings over 20 years of medical technology and life sciences leadership experience, including prior roles at Hill-Rom (managing commercial operations across Asia), A*STAR (Singapore's national science and technology agency), and MedMined Inc., an AI-driven healthcare analytics firm acquired by Cardinal Health; he holds an MBA from Nanyang Business School and an MS in Healthcare Informatics from the University of Alabama at Birmingham.
Board
AA
Abel AngChairman and Group Chief Executive Officer of Advanced MedTech
Investors · 4
Also in the syndicate · 2
Advanced MedTechLion X Ventureslead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BSep 2023
Lion X Ventures (lead), Vickers Venture Partners (lead), Advanced MedTech, Eckuity Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Vivance do?
- AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.
- Who are Vivance's investors?
- Vivance's investors include Vickers Venture Partners, Eckuity.
- Where is Vivance headquartered?
- Vivance is headquartered in Singapore, SG.